Clinical Trial Update: A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial of BL-M24D1 in patients with relapsed or refractory multiple myeloma and other hematologic malignancies; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Multiple Myeloma

Drugs mentioned

• BL-M24D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Multiple Myeloma, Hematologic Malignancies | Phase 1 | Status: NOT_YET_RECRUITING